🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Uber, Pfizer, Tesla, Carvana Rise Premarket; Eli Lilly Falls

Published 11/01/2022, 07:38 AM
Updated 11/01/2022, 07:53 AM
© Reuters
LLY
-
MNST
-
PFE
-
JNJ
-
MPC
-
TSLA
-
ABMD
-
BP
-
PSX
-
CVNA
-
UBER
-

By Peter Nurse

Investing.com -- Stocks in focus in premarket trade on Tuesday, November 1st. Please refresh for updates.

  • Uber (NYSE:UBER) stock soared 10.4% after the ride-hailing firm forecast fourth quarter operating profit above expectations, betting on rising demand for its rides as customers resume spending more on travel and tight control on costs.

  • Pfizer (NYSE:PFE) stock rose 4.1% after the drugmaker raised its full-year estimates for sales of its COVID-19 vaccine by $2 billion to $34 billion, encouraged by demand for its new booster shots.

  • Eli Lilly (NYSE:LLY) stock fell 1.9% after the drugmaker cut its full-year profit forecast, as it struggles with lower insulin prices and generic competition for its cancer drug.

  • Abiomed (NASDAQ:ABMD) stock soared 52% after Johnson & Johnson (NYSE:JNJ), down 0.5%, announced plans to acquire the medical technology provider for $380 per share in cash, an enterprise value of nearly $16.6 billion.

  • Marathon Petroleum (NYSE:MPC) stock rose 1.5% after the refiner reported a jump in quarterly profit, on the back of a surge in demand for fuel and refined products amid tight supplies.

  • Phillips 66 (NYSE:PSX) stock rose 0.7% after the refiner reported a jump in quarterly profit, benefiting from surging fuel demand and tight energy supplies.

  • Tesla (NASDAQ:TSLA) stock rose 2% after Reuters reported that the electric vehicle manufacturer aims to start mass production of its Cybertruck at the end of 2023, two years after the initial target for the long-awaited pickup truck.

  • Carvana (NYSE:CVNA) stock soared 12.1% after JPMorgan upgraded its investment stance on the used car retailer to 'neutral' from 'underweight', saying investors now have a better handle on the risks involved.

  • Monster Beverage (NASDAQ:MNST) stock rose 2.3% after JPMorgan upgraded its stance on the energy drinks manufacturer to 'overweight' from 'neutral', saying it has an attractive valuation.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.